SV2016005317A - DERIVATIVES OF PIRROLIDINE -2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORS - Google Patents
DERIVATIVES OF PIRROLIDINE -2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORSInfo
- Publication number
- SV2016005317A SV2016005317A SV2016005317A SV2016005317A SV2016005317A SV 2016005317 A SV2016005317 A SV 2016005317A SV 2016005317 A SV2016005317 A SV 2016005317A SV 2016005317 A SV2016005317 A SV 2016005317A SV 2016005317 A SV2016005317 A SV 2016005317A
- Authority
- SV
- El Salvador
- Prior art keywords
- pirrolidine
- diona
- derivatives
- methods
- pharmaceutical compositions
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE AL COMPUESTO DE LA FÓRMULA I: (VER FORMULA); O SUS ENANTIÓMEROS, SALES, SOLVATOS O PROFÁRMACOS FARMACÉUTICAMENTE ACEPTABLES. LA INVENCIÓN TAMBIÉN SE REFIERE AL USO DE LOS COMPUESTOS DE LA FÓRMULA I COMO INHIBIDORES DE IDO1. LA INVENCIÓN TAMBIÉN SE REFIERE AL USO DE LOS COMPUESTOS DE LA FÓRMULA 1 PARA EL TRATAMIENTO Y/O LA PREVENCIÓN DE CÁNCER Y ENDOMETRIOSIS. LA INVENCIÓN TAMBIÉN SE REFIERE A UN PROCESO PARA PREPARAR LOS COMPUESTOS DE LA FÓRMULA ITHE PRESENT INVENTION REFERS TO THE COMPOUND OF FORMULA I: (SEE FORMULA); OR ITS ENANTIOMERS, SALTS, SOLVATOS OR PHARMACEUTICALLY ACCEPTABLE PROPHARMS. THE INVENTION ALSO REFERS TO THE USE OF THE COMPOUNDS OF FORMULA I AS IDO INHIBITORS1. THE INVENTION ALSO REFERS TO THE USE OF THE COMPOUNDS OF FORMULA 1 FOR THE TREATMENT AND / OR PREVENTION OF CANCER AND ENDOMETRIOSIS. THE INVENTION ALSO REFERS TO A PROCESS FOR PREPARING THE COMPOUNDS OF FORMULA I
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461996976P | 2014-05-15 | 2014-05-15 | |
| EP14168534 | 2014-05-15 | ||
| BE2014/0754A BE1021251B1 (en) | 2014-05-15 | 2014-10-21 | PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AS INHIBITORS OF IDO1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2016005317A true SV2016005317A (en) | 2017-07-10 |
Family
ID=59858293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2016005317A SV2016005317A (en) | 2014-05-15 | 2016-11-11 | DERIVATIVES OF PIRROLIDINE -2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORS |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2017214409A (en) |
| BR (1) | BR112016026346A8 (en) |
| CL (1) | CL2016002899A1 (en) |
| NI (1) | NI201600171A (en) |
| PH (1) | PH12016502281A1 (en) |
| SV (1) | SV2016005317A (en) |
| ZA (1) | ZA201607127B (en) |
-
2015
- 2015-05-14 BR BR112016026346A patent/BR112016026346A8/en not_active Application Discontinuation
-
2016
- 2016-10-17 ZA ZA2016/07127A patent/ZA201607127B/en unknown
- 2016-11-11 NI NI201600171A patent/NI201600171A/en unknown
- 2016-11-11 SV SV2016005317A patent/SV2016005317A/en unknown
- 2016-11-15 PH PH12016502281A patent/PH12016502281A1/en unknown
- 2016-11-15 CL CL2016002899A patent/CL2016002899A1/en unknown
-
2017
- 2017-07-11 JP JP2017135754A patent/JP2017214409A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016026346A8 (en) | 2021-07-20 |
| CL2016002899A1 (en) | 2017-06-02 |
| JP2017214409A (en) | 2017-12-07 |
| NI201600171A (en) | 2017-01-03 |
| PH12016502281A1 (en) | 2017-02-13 |
| BR112016026346A2 (en) | 2017-08-15 |
| ZA201607127B (en) | 2018-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY36122A (en) | ? DERIVATIVES OF PIRROLIDINA-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORS? | |
| MX2022012313A (en) | OXISTEROLS AND METHODS OF USE THEREOF. | |
| DOP2017000151A (en) | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | |
| CO2018001268A2 (en) | Heteroaryl derivatives as parp inhibitors | |
| CO2018000589A2 (en) | Oxiesterols and pharmaceutical compositions containing them | |
| DOP2015000158A (en) | PRMT5 INHIBITORS AND THEIR USES | |
| MD20160106A2 (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as IRAK4 inhibitors | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| MX2016014253A (en) | Inhibitors of lysine specific demethylase-1. | |
| UY35617A (en) | 3-QUINASA PHOSFATIDYLINOSITOL INHIBITORS | |
| UY35242A (en) | 3-QUINASA PHOSFATIDYLINOSITOL INHIBITORS | |
| NZ726608A (en) | Phosphatidylinositol 3-kinase inhibitors | |
| MX2016017110A (en) | Phosphatidylinositol 3-kinase inhibitors. | |
| MX2018005725A (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer. | |
| NZ726360A (en) | Phosphatidylinositol 3-kinase inhibitors | |
| MX2022005298A (en) | INTERMEDIATE COMPOUNDS FOR THE SYNTHESIS OF A2A INHIBITORS. | |
| NZ726638A (en) | Phosphatidylinositol 3-kinase inhibitors | |
| MX2018001992A (en) | Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors. | |
| MY181641A (en) | Amino pyran ring derivative and composition and use thereof | |
| CU20170007A7 (en) | IMIDAZOPIRIDAZINE COMPOUNDS | |
| MX387796B (en) | AMINOCARBONYLCRBAMATE COMPOUNDS. | |
| CU20160195A7 (en) | QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS | |
| TR201819805T4 (en) | FLAVAGLIN DERIVATIVES. | |
| SV2016005310A (en) | DERIVATIVES OF DIHETEROCICLO LINKED TO CYCLALKYL | |
| SV2016005317A (en) | DERIVATIVES OF PIRROLIDINE -2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORS |